Diabetes, Vol 48, Issue 3 484-490, Copyright © 1999 by American Diabetes Association

ARTICLES

Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients

BO Roep, I Stobbe, G Duinkerken, JJ van Rood, A Lernmark, B Keymeulen, D Pipeleers, FH Claas and RR de Vries
Department of Immunohaematology and Blood Bank, University Hospital Leiden, The Netherlands. broep@pobox.leidenuniv.nl

Allogeneic islet transplantation can restore an insulin-independent state in C-peptide-negative type 1 diabetic patients. We recently reported three cases of surviving islet allografts that were implanted in type 1 diabetic patients under maintenance immune suppression for a previous kidney graft. The present study compares islet graft-specific cellular auto- and alloreactivity in peripheral blood from those three recipients and from four patients with failing islet allografts measured over a period of 6 months after portal islet implantation. The three cases that remained C-peptide-positive for >1 year exhibited no signs of alloreactivity, and their autoreactivity to islet autoantigens was only marginally increased. In contrast, rapid failure (<3 weeks) in three other cases was accompanied by increases in precursor frequencies of graft-specific alloreactive T-cells; in one of them, the alloreactivity was preceded by a sharply increased autoreactivity to several islet autoantigens. One recipient had a delayed loss of islet graft function (33 weeks); he did not exhibit signs of graft-specific alloimmunity, but developed a delayed increase in autoreactivity. The parallel between metabolic outcome of human beta-cell allografts and cellular auto- and alloreactivity in peripheral blood suggests a causal relationship. The present study therefore demonstrates that T-cell reactivities in peripheral blood can be used to monitor immune mechanisms, which influence survival of beta-cell allografts in diabetic patients.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. R. Rickels, M. Kamoun, J. Kearns, J. F. Markmann, and A. Naji Evidence for Allograft Rejection in an Islet Transplant Recipient and Effect on {beta}-Cell Secretory Capacity J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2410 - 2414. [Abstract] [Full Text] [PDF]

				F. Bertuzzi and C. Ricordi Prediction of Clinical Outcome in Islet Allotransplantation Diabetes Care, February 1, 2007; 30(2): 410 - 417. [Full Text] [PDF]

				B. Keymeulen, P. Gillard, C. Mathieu, B. Movahedi, G. Maleux, G. Delvaux, D. Ysebaert, B. Roep, E. Vandemeulebroucke, M. Marichal, et al. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft PNAS, November 14, 2006; 103(46): 17444 - 17449. [Abstract] [Full Text] [PDF]

				V. A.L. Huurman, J. S. Kalpoe, P. van de Linde, N. Vaessen, J. Ringers, A. C.M. Kroes, B. O. Roep, and J. W. De Fijter Choice of Antibody Immunotherapy Influences Cytomegalovirus Viremia in Simultaneous Pancreas-Kidney Transplant Recipients Diabetes Care, April 1, 2006; 29(4): 842 - 847. [Abstract] [Full Text] [PDF]

				G. G.M. Pinkse, W. P. Bouwman, R. Jiawan-Lalai, O.T. Terpstra, J. A. Bruijn, and E. de Heer Integrin Signaling via RGD Peptides and Anti-{beta}1 Antibodies Confers Resistance to Apoptosis in Islets of Langerhans Diabetes, February 1, 2006; 55(2): 312 - 317. [Abstract] [Full Text] [PDF]

				G. G. M. Pinkse, O. H. M. Tysma, C. A. M. Bergen, M. G. D. Kester, F. Ossendorp, P. A. van Veelen, B. Keymeulen, D. Pipeleers, J. W. Drijfhout, and B. O. Roep Autoreactive CD8 T cells associated with {beta} cell destruction in type 1 diabetes PNAS, December 20, 2005; 102(51): 18425 - 18430. [Abstract] [Full Text] [PDF]

				A. G.S. van Halteren, E. van Etten, E. C. de Jong, R. Bouillon, B. O. Roep, and C. Mathieu Redirection of Human Autoreactive T-Cells Upon Interaction With Dendritic Cells Modulated by TX527, an Analog of 1,25 Dihydroxyvitamin D3 Diabetes, July 1, 2002; 51(7): 2119 - 2125. [Abstract] [Full Text] [PDF]

				E. Bosi, S. Braghi, P. Maffi, M. Scirpoli, F. Bertuzzi, G. Pozza, A. Secchi, and E. Bonifacio Autoantibody Response to Islet Transplantation in Type 1 Diabetes Diabetes, November 1, 2001; 50(11): 2464 - 2471. [Abstract] [Full Text] [PDF]

				S A White, R Kimber, P S Veitch, and M L Nicholson Surgical treatment of diabetes mellitus by islet cell and pancreas transplantation Postgrad. Med. J., June 1, 2001; 77(908): 383 - 387. [Full Text]

				A. Lernmark Type 1 Diabetes Clin. Chem., August 1, 1999; 45(8): 1331 - 1338. [Abstract] [Full Text] [PDF]